Current scenario of COVID-19 in pediatric age group and physiology of immune and thymus response
- PMID: 32425651
- PMCID: PMC7227606
- DOI: 10.1016/j.sjbs.2020.05.024
Current scenario of COVID-19 in pediatric age group and physiology of immune and thymus response
Abstract
COVID-19 pandemic caused by SARS-CoV-2, continues to manifest with severe acute respiratory syndrome among the adults, however, it offers a convincing indication of less severity and fatality in pediatric age group (0-18 years). The current trend suggests that children may get infected but are less symptomatic with less fatality, which is concordant to earlier epidemic outbreaks of SARS-CoV and MERS-CoV, in 2002 and 2012, respectively. According to the available data, children appear to be at lower risk for COVID-19, as adults constitute for maximum number of the confirmed cases (308,592) and deaths (13,069) as on 22nd March (https://www.worldometers.info/coronavirus). However, rapid publications and information of the adult patients with COVID-19 is in progress and published, on the contrary, almost no comprehensive data or discussion about the COVID-19 in children is available. Therefore, in this review, we outline the epidemiology, clinical symptoms, diagnosis, treatment, prevention, possible immune response and role of thymus in children to combat the COVID-19 outbreak.
Keywords: ARDS, Acute Respiratory Distress Syndrome; COVID-19; COVID-19, Coronavirus Disease-2019; Children; Coronaviruses; Immunity; MERS-CoV, Middle East Respiratory Syndrome Coronavirus; Pandemic; SARS-CoV, Severe Acute Respiratory Syndrome Coronavirus; Thymus; WHO, World Health Organization; pp1ab, Polyprotein 1ab.
© 2020 The Author(s).
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
